Beta Bionics Inc [BBNX] stock prices are down -1.77% to $15.56 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BBNX shares have gain 21.18% over the last week, with a monthly amount glided 49.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Beta Bionics Inc [NASDAQ: BBNX] stock has seen the most recent analyst activity on February 24, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $25. Previously, Piper Sandler started tracking the stock with Overweight rating on February 24, 2025, and set its price target to $26. On February 24, 2025, Leerink Partners initiated with a Outperform rating and assigned a price target of $28 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $30 on February 24, 2025. BofA Securities initiated its recommendation with a Buy. Robert W. Baird started tracking with a Neutral rating for this stock on February 20, 2025, and assigned it a price target of $20. In a note dated February 20, 2025, Ladenburg Thalmann initiated an Neutral rating and provided a target price of $20 on this stock.
The stock price of Beta Bionics Inc [BBNX] has been fluctuating between $8.89 and $24.50 over the past year. Beta Bionics Inc [NASDAQ: BBNX] shares were valued at $15.56 at the most recent close of the market.
Analyzing the BBNX fundamentals
Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at -0.77%, Pretax Profit Margin comes in at -1.02%, and Net Profit Margin reading is -1.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.2, Equity is -0.57 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Beta Bionics Inc [NASDAQ:BBNX]’s Current Ratio is 15.88. Also, the Quick Ratio is 14.93, while the Cash Ratio stands at 2.57.
Transactions by insiders
Recent insider trading involved Mensinger Mike, Chief Product Officer, that happened on Jan 31 ’25 when 33350.0 shares were purchased. Chief Product Officer, Mensinger Mike completed a deal on Jan 31 ’25 to sell 13.0 shares. Meanwhile, 10% Owner Wellington Hadley Harbor Aggre bought 1.0 million shares on Jan 31 ’25.
